Long-Term Efficacy and Safety of Fenofibrate and a Statin in the Treatment of Combined Hyperlipidemia

This publication has 20 references indexed in Scilit:

• Role of Lp A-I and Lp A-I/A-II in Cholesteryl Ester Transfer Protein–Mediated Neutral Lipid Transfer
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia
  The American Journal of Medicine, 1993
• Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
  Circulation, 1992
• Lovastatin/Gemfibrozil Myopathy: A Clinical, Histochemical, and Ultrastructural Study
  European Neurology, 1992
• Long-term safety and efficacy profile of simvastatin
  The American Journal of Cardiology, 1991
• Cholesterol‐lowering agent myopathy (CLAM)
  Neurology, 1991
• Lovastatin-induced acute rhabdomyolysis
  Published by Oxford University Press (OUP) ,1990
• Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
  Circulation, 1989
• The role of cholesterol‐lowering agents in drug‐induced rhabdomyolysis and polymyositis
  Arthritis & Rheumatism, 1989
• Kinetic bases of the primar hperlipidaemias: studies of apolipoprotein B turnover in geneticall defined subjects
  European Journal of Clinical Investigation, 1980